<code id='FB4EA6316D'></code><style id='FB4EA6316D'></style>
    • <acronym id='FB4EA6316D'></acronym>
      <center id='FB4EA6316D'><center id='FB4EA6316D'><tfoot id='FB4EA6316D'></tfoot></center><abbr id='FB4EA6316D'><dir id='FB4EA6316D'><tfoot id='FB4EA6316D'></tfoot><noframes id='FB4EA6316D'>

    • <optgroup id='FB4EA6316D'><strike id='FB4EA6316D'><sup id='FB4EA6316D'></sup></strike><code id='FB4EA6316D'></code></optgroup>
        1. <b id='FB4EA6316D'><label id='FB4EA6316D'><select id='FB4EA6316D'><dt id='FB4EA6316D'><span id='FB4EA6316D'></span></dt></select></label></b><u id='FB4EA6316D'></u>
          <i id='FB4EA6316D'><strike id='FB4EA6316D'><tt id='FB4EA6316D'><pre id='FB4EA6316D'></pre></tt></strike></i>

          knowledge

          knowledge

          author:explore    Page View:376
          Illustration of a brain maze. -- biotech coverage from STAT
          Adobe

          The brain remains both the body’s most important organ and its least understood. But a draft atlas of the human brain published on Thursday gives scientists important insights into how it works and may pave the way for big advances in disease treatment and diagnosis.

          This brain map, pieced together by hundreds of researchers from San Diego to Seattle to Stockholm, is essentially a cellular “parts list” of the human brain and a guide to how those pieces are arranged and work together. Scientists say that what they’ve already learned — including a stunning diversity of cell types in the brain — and what they’ll discover in the years to come will improve our understanding of deadly neurological diseases.

          advertisement

          At the heart of this effort are some of biology’s most fundamental questions. How do mutations contribute to disease? What makes people different from one another? And what makes humans different from other primates?

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes
          U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

          DarronCummings/APLONDON—AU.K.governmentagencyonTuesdaysaidthatitwon’trecommendEliLilly’sMounjaro—par

          read more
          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more

          Can medical device makers keep up in the race to treat obesity?

          KatyLemayforSTATThemakersofminimallyinvasivesurgicaldevicesseemedpoisedtocaptureawideswathoftheobesi